Nalaganje...

Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations

The introduction in clinical practice of pharmaceutical products known as biosimilars, as part of a more complex series of progress in the field of biological drugs, represents an excellent therapeutic resource. A biosimilar drug is a biological/biotechnological drug that is highly similar to an app...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Ther
Main Authors: Francescon, Sara, Fornasier, Giulia, Baldo, Paolo
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5315076/
https://ncbi.nlm.nih.gov/pubmed/28261647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-016-0028-9
Oznake: Označite
Brez oznak, prvi označite!